http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110087636-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81b72c21ca3bc0deda1bd75bd00b535a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
filingDate 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63694ca91eb75e80b293f86d2e3cf28c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92b1405730905361ba0e0cf1ac790081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aba7dc5f30f87ba493c8aa9a95ba60c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b389e12003d496c0419b446eec43f75f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beb1a90c2a16ceaeb784be8564dd7155
publicationDate 2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110087636-A
titleOfInvention Ophthalmic Distribution and Pharmacokinetics of Rifester Formulations
abstract The present invention provides Rifester formulations for use in the treatment of immune-related diseases of the ocular surface. The formulations and methods provided herein are particularly useful for treating anterior segment tissue.
priorityDate 2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012252756-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009128934-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9986
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID557797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5719
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281877
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426355423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504175
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16414
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451829678
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID458607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11965427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID309684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3689
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447917097

Total number of triples: 56.